However, increased PD-L1 expression has also been reported to be a favorable prognostic factor in patients with NSCLC [28], small cell lung cancer [29], gastric cancer [30], pancreatic cancer [31] and tonsillar cancer [32]. This evidence concerns the gene CD274 and small cell lung carcinoma.